NeuPath Health Inc (NPTH) — Strategic Asset Allocation Index
NeuPath Health Inc (NPTH) has a Strategic Asset Allocation Index of 53.3% as of December 2022. Strategic assets (PP&E of CA$11.54 Million plus long-term investments of CA$-) total CA$11.54 Million, measured against net assets of CA$21.65 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
NeuPath Health Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how NeuPath Health Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of December 2022, the index stands at 53.3%, representing strategic assets of CA$11.54 Million against net assets of CA$21.65 Million CAD. Explore NPTH cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for NeuPath Health Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for NeuPath Health Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of NeuPath Health Inc.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 53.3% | CA$11.54 Million | CA$11.54 Million | CA$- | CA$21.65 Million | ▲ +8.4 pp |
| 2021 | 44.9% | CA$11.60 Million | CA$11.60 Million | CA$- | CA$25.83 Million | ▲ +20.9 pp |
| 2020 | 24.0% | CA$6.63 Million | CA$6.63 Million | CA$- | CA$27.62 Million | ▼ -60.1 pp |
| 2019 | 84.1% | CA$8.22 Million | CA$8.22 Million | CA$- | CA$9.77 Million | — |